We propose a strategy in which decoys of CD47 that are not directly linked to an active “eat me” signal are delivered by gene-modified T cells directly in tumors and appropriate tumor antigen–specific Ab(s) bearing an active Fc tail are coadministered to lower the phagocytic threshold against the tumor cells. This evidence concerns the gene CD47 and neoplasm.